Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the context of a clinical trial involving the combination of ABX196 and nivolumab for patients with hepatocellular carcinoma.
    Difference
    0.1%
    Check dated 2024-06-06T14:34:11.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to provide a detailed description of eligibility criteria, including examples such as general health condition or prior treatments, and directs users to 'Learn About Studies' for more information. The new description also specifies inclusion and exclusion criteria for participants in the clinical study.
    Difference
    26%
    Check dated 2024-05-22T21:21:53.000Z thumbnail image
  8. Check
    22 days ago
    Change Detected
    Summary
    The value 'No Posted' on the webpage has recently changed to 'Submitted.' This change likely indicates that the publication or documentation related to medical and healthcare has been submitted for review or publication.
    Difference
    0.2%
    Check dated 2024-05-21T14:48:21.000Z thumbnail image
  9. Check
    43 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:47:40.000Z thumbnail image

Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.